H. pylori infection

临床试验

计划入组 300 人 · 首次发布于 2025 年 12 月 29 日

已完成

NCT02547025

Personalized Treatment for Refractory H Pylori Infection

计划入组 126 人 · 首次发布于 2015 年 9 月 11 日

已完成

NCT06823791

Furazolidone Quadruple Regimen Eradicate H. Pylori Infection

计划入组 493 人 · 首次发布于 2025 年 2 月 12 日

药物

查看全部 1196 →

Small Molecule

Approved

Omeprazole(Konvomep, Losec, Omeclamox, Omesec, Previdolrx Analgesic Pak, Prilosec, Talicia, Yosprala, Zegerid, Zegerid Reformulated Aug 2006, Zegerid With Magnesium Hydroxide)

生产企业：Apotex inc, Dr reddys laboratories ltd，另有 9 家

相关疾病：Ankylosing Spondylitis (AS), Duodenal Ulcer，另有 14 项

C₁₇H₁₉N₃O₃S

multi-targeting drug conjugate (Helicobacter pylori infection)

Helicobacter pylori therapy 2 (Biotie)

机构

查看全部 135 →

H & H EXPORTS, LLC

United States

LG H&H Co., Ltd.

South Korea

FIRST MEDICAL INFECTION CONTROL ASSOCIATES, INC.

United States

资讯

查看全部 3654 →

去年

TenNor's Rifasutenizol Demonstrates Superior Efficacy Against H. pylori in Phase III Trial

去年

TenNor's Rifasutenizol Demonstrates Superior Efficacy Against H. pylori in Phase III Trial

去年

临床试验

H. Pylori Infection and AIP Levels

Personalized Treatment for Refractory H Pylori Infection

Furazolidone Quadruple Regimen Eradicate H. Pylori Infection

药物

Omeprazole(Konvomep, Losec, Omeclamox, Omesec, Previdolrx Analgesic Pak, Prilosec, Talicia, Yosprala, Zegerid, Zegerid Reformulated Aug 2006, Zegerid With Magnesium Hydroxide)

multi-targeting drug conjugate (Helicobacter pylori infection)

Helicobacter pylori therapy 2 (Biotie)

机构

H & H EXPORTS, LLC

LG H&H Co., Ltd.

FIRST MEDICAL INFECTION CONTROL ASSOCIATES, INC.

资讯

TenNor's Rifasutenizol Demonstrates Superior Efficacy Against H. pylori in Phase III Trial

TenNor's Rifasutenizol Demonstrates Superior Efficacy Against H. pylori in Phase III Trial

TenNor's Rifasutenizol Achieves High Eradication Rate in Phase III H. pylori Trial